Incidence and Outcomes of Brain Metastasis in Pleural Mesothelioma in the Era of Immunotherapy

Incidence and Outcomes of Brain Metastasis in Pleural Mesothelioma in the Era of Immunotherapy

Introduction: Immunotherapy (IO) has reported efficacy in pleural mesothelioma (PM). Brain metastases (BMs) in PM are rare; thus, surveillance brain imaging is not included in the guidelines. We evaluated the incidence of BM by treatment type. Methods: In this retrospective analysis, patients with P...

Full description

Saved in:
Bibliographic Details
Main Authors: Margaret Stalker, MD, Suzanne L. Walker, PhD, CRNP, AOCN, BC, Emily Lebow, MD, Emily Ling-Lin Pai, MD, PhD, Alex Watts, MS, Wei-Ting Hwang, PhD, Amir Banihashemi, MD, Evan Anderson, MSN, Leonid Roshkovan, MD, Sharyn I. Katz, MD, Leslie Litzky, MD, Andrew R. Haas, MD, PhD, Sunil Singhal, MD, Corey J. Langer, MD, Keith Cengel, MD, PhD, Melina E. Marmarelis, MD, MSCE
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:JTO Clinical and Research Reports
Subjects:
Mesothelioma
Immunotherapy
Brain metastasis
Survival
Pleural mesothelioma
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364325000396
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2666364325000396

Similar Items